Burden of liver cancer attributable to hepatitis B and alcohol globally, in China, and for five sociodemographic index regions from 1990 to 2021
2024-11-13
(Press-News.org) Background and Aims
Liver cancer is a digestive system malignancy that poses a significant public health challenge globally. This study aimed to analyze and compare the epidemiological trends of liver cancer attributed to hepatitis B (LCHB) and alcohol use (LCAL) over the past 32 years.
Methods
Data on mortality and disability-adjusted life years for LCHB and LCAL in China, globally, and across five sociodemographic index regions were obtained from the Global Burden of Disease 2021 database and comprehensively analyzed.
Results
In 2021, the global and Chinese death counts and disability-adjusted life years attributed to LCHB and LCAL showed substantial increases compared to 1990. China had the highest number of deaths from LCHB and LCAL among 204 countries and regions. Gender and age disparities were notable, with males and those aged 40–75 years bearing a higher burden than females and other age groups. Global age-period-cohort analysis revealed an escalating risk of death from LCHB with age, alongside a lower risk in younger cohorts and more recent periods. The mortality risk for LCAL also increased with age but exhibited distinct cohort and period effects compared to LCHB. Decomposition analysis indicated that shifts in the global burden of LCHB and LCAL were influenced by population growth, with population aging playing a crucial role in China.
Conclusions
A significant burden of LCHB and LCAL persists, highlighting the need for tailored prevention, screening, and control strategies to mitigate their incidence, as well as the identification of advanced therapeutics to reduce mortality.
Full text
https://www.xiahepublishing.com/2310-8819/JCTH-2024-00351
The study was recently published in the Journal of Clinical and Translational Hepatology.
The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-11-13
One only needs to glance at the news, social media, or even just out the window to understand the devastation caused by flooding. Recent back-to-back major hurricanes have brought catastrophic rainfall that has devastated communities across the southeastern United States.
With climate change, experts predict these extreme weather events will increasingly become the norm. Among the many ways that researchers are devising strategies to protect and assist vulnerable areas, one such effort involves increasing the speed and accuracy of damage assessments.
“Research ...
2024-11-13
Stories on the discovery of vital fluid-transport systems in the human body are among the winners of the 2024 AAAS Kavli Science Journalism Awards. Winning journalists also did immersive stories on scientists and physicians at work – in the field, in the lab and in the emergency room.
Independent panels of science journalists select the winners of the awards, which are administered by the American Association for the Advancement of Science (AAAS) and endowed by The Kavli Foundation. There is a Gold Award ($5,000) and Silver Award ($3,500) for each of the eight categories. The global awards program drew entries ...
2024-11-13
Mass General Brigham AI is hosting the Healthcare AI Challenge, a multi-institutional virtual, interactive series of events where healthcare professionals can explore and assess the latest AI healthcare technologies in real-world healthcare scenarios.
The Healthcare AI Challenge Collaborative is launching with a diverse set of healthcare institutions and their healthcare professionals, including Mass General Brigham; Emory Healthcare; the Department of Radiology at the University of Wisconsin School of Medicine and Public Health; and the Department of Radiology at the University of Washington School of Medicine. The American College of Radiology (ACR), ...
2024-11-13
NEW YORK, NY— The American Federation for Aging Research (AFAR) is pleased to announce the recipients of its 2024 AFAR Grants for Junior Faculty. The AFAR Grants for Junior Faculty program provides up to $150,000 for a one- to two-year award to junior faculty (MDs and PhDs) to conduct research that will serve as the basis for longer term research efforts on the biology of aging. The major goal of this program is to assist in the development of the careers of early career investigators committed to pursuing careers in aging research. Selected through ...
2024-11-13
Highlights:
An FDA-approved vaccine for smallpox and mpox is effective but causes side effects. The other requires multiple doses.
An experimental single-dose vaccine uses the horsepox virus to harness the benefits of both strategies.
Previous studies suggest that inoculation with horsepox elicits an antibody response to mpox and provides 100% protection in animal models.
New data show that the horsepox virus is significantly more attenuated, or weakened, compared to the virus used in the FDA-approved live virus vaccine.
Washington, D.C.—Vaccines that prevent smallpox and mpox come in 2 varieties. One uses a single shot of a live virus but ...
2024-11-13
The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, today announced four winning project groups, consisting of seven individuals, of its second annual Spark Grant program. The program was created to fund gene and cell therapy projects by Mass General Brigham investigators that demonstrate tangible advancements towards clinical applications and commercialization outcomes, including licensing, partnerships, or new company creation. A total of $1,150,000 ...
2024-11-13
CLEVELAND—Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.
In a new study, published in the journal Cell Reports, they identified an inflammation-reducing molecule—called itaconate (ITA)—that could be the foundation of a new approach to treat such a common and deadly disease.
Heart disease is the leading cause of death for ...
2024-11-13
A research team led by Dr. Jung-Je Woo at the Gwangju Clean Energy Research Center of the Korea Institute of Energy Research (KIER) has successfully developed a cost-effective and eco-friendly technology for recycling cathode materials* from spent lithium-ion batteries.
*Cathode Materials: Materials that play a crucial role in generating electricity by storing and releasing lithium ions during battery charging and discharging.
With the recent rise in electric vehicles and mobile devices, managing spent batteries has become a critical global challenge. By 2040, the number of decommissioned electric vehicles is expected to exceed 40 million*, leading ...
2024-11-13
Most people don’t enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A study in the Journal of the American Chemical Society reports steps toward making inhalable mRNA medicines a possibility. Researchers outline their improved lipid-polymer nanoparticle for holding mRNA that is stable when nebulized and successfully delivers aerosols (liquid droplets) in mice’s lungs.
mRNA ...
2024-11-13
X-rays are a common component of diagnostic testing and industrial monitoring, used for everything from monitoring your teeth to scanning your suitcase at the airport. But the high-energy rays also produce ionizing radiation, which can be dangerous after prolonged or excessive exposures. Now, researchers publishing in ACS Central Science have taken a step toward safer X-rays by creating a highly sensitive and foldable detector that produces good quality images with smaller dosages of the rays.
“This advancement reduces detection limits and paves the way for safer and more energy-efficient medical imaging and industrial monitoring,” says Omar F. Mohammed, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Burden of liver cancer attributable to hepatitis B and alcohol globally, in China, and for five sociodemographic index regions from 1990 to 2021
